Alcon gets U.S. clearance for BRYTLY redness-relief drops
+1 new source since this summary was written
On Oct 16, 2026, the U.S. Food and Drug Administration authorized Alcon’s BRYTLY over-the-counter eye drops. Alcon said a single drop begins reducing eye redness in one minute, with effects lasting up to 12 hours, and that the product lasts 50% longer than Lumify. The company plans to introduce BRYTLY through nationwide retail and online channels in the coming months.
Why it matters
The approval gives Alcon a new consumer eye-care product and permits its U.S. commercial rollout. Wider distribution is expected in the coming months, creating a new product opportunity for Alcon while adding competition to the redness-relief category.
Key facts
- 1The FDA approved Alcon’s BRYTLY Redness Reliever Eye Drops on Oct 16, 2026. rutlandherald.com
- 2Alcon says BRYTLY starts working in one minute and provides effects for up to 12 hours. rutlandherald.com
- 3The company says BRYTLY lasts 50% longer than Lumify, based on label claims of up to 12 hours versus up to 8 hours. stocktitan.net
- 4Alcon expects BRYTLY to reach major retailers and online outlets in the coming months. rutlandherald.com
Summary written by AlphAI AI Desk from 4 of 4 sources. Not investment advice. Figures are as stated by the linked sources.